|
Main Conference
11:30am Main Conference Registration
1:00pm Chairperson’s Opening Remarks
1:15 Theoretical Framework: Project Templates that Facilitate Portfolio Analysis
The cost of deploying an enterprise-wide project management system in the pharmaceutical industry can range from $8 million to $80 million but the estimated returns on investments are rarely achieved. Major causes for this failure include anachronistically designed project templates - a.k.a. Work Breakdown Structures,
(WBS) that fail to align funding horizons with the governing committee's line of authorities. In order to realize the financial benefits of implementing an enterprise-wide project management system, it is essential to establish a logical WBS design. Poorly defined WBS hinders the process of performing meaningful portfolio analysis. This presentation will:
• Discuss a basic WBS design principle and provide a rational process for correcting this
problem
• Provide a guideline for defining the drug development project - from NCE to
supplemental filings - into relevant and actionable “portfolio building blocks”
• Describe how this optimizing model can help to achieve a positive ROI for the
project
management system
Melquiades de Jesus, Associate Director, Resource Planning, Resource Management and Planning, Bristol-Myers Squibb
|
CASE
STUDY |
2:00 Research Program Planning: How Research Innovation Coordinates with Project, Portfolio and Resource Management in a Biopharmaceutical Company
Research Program Planning (RPP) is the branch of project management designed to manage research innovation that generates long term value. It provides the discipline that drives Research to undertake well-defined and adequately resourced projects that deliver drug candidates that the organization truly wants to develop. RPP provides decision support and change management to the research teams, and communication to the wider organization. It effectively links departmental (line function) strategy and operations with corporate goals. This talk will provide examples of these points and practical suggestions for how project management can contribute to Research innovation.
James Paterniti, PhD, Senior Director Research Program Planning, Project Management, Amylin Pharmaceuticals Inc.
|
|
CASE
STUDY |
2:45 Better Therapeutic Development through a Collaborative, “Information-Centric” Tool
Array Biopharma, Inc. is adapting an existing innovative technology to support the management and interface of drug discovery and development. This technology and visual tool are expected to facilitate the difficulties in managing the parallel execution of multiple projects. Array is co-developing a collaborative decision support and project management environment with General Dynamics VIZ in which the entire team can review and discuss the projects as the work progresses. Through our approach, project plans, work progress, and scientific results are updated and disseminated automatically, so all relevant data is at hand for the scientists making the decisions. In this talk, we will:
• Describe why a different approach to project management is warranted
• Assert that a collaborative, “information-centric” environment will drive better
project results by drawing on examples from other industries
• Present a case study of our progress and results, and highlight the architectural consideration, cultural issue, and long-term prospectus of this new approach to developing therapeutics
James Rizzi, PhD, Director of Computational Technology, Scientific Computing, Array
Biopharma, Inc.
|
3:30 Afternoon Break
INTERACTIVE BREAKOUT GROUP DISCUSSIONS
3:45 Executive Roundtables
Concurrent roundtables to discuss some of the more broad yet poignant questions facing the industry. Each roundtable will be limited to twelve (12) participants and a facilitator.
- How Do You Re-allocate a Successful Project Team?
- Does Project Management Really Drive Project Strategy or Is This the Role of the Team Leader?
- What IT Systems Are in Place to Support the Ever Changing Landscape of Project Management Information?
- What is the Best Project Management Model to Use in Staffing the Project Management Function?
- Project and Portfolio Prioritization: Best Practices in Redesigning Stage Gate Management Criteria
Facilitator: John Connelly, Associate Director, Program Management, Genzyme Corporation
- Development and Implementation of Risk Mitigation Strategies through Project Management
4:45 Networking Refreshment Break
5:15 Executive Panel: Roundtable Synopsis and Findings
Each roundtable group will designate a leader to sit on a panel and present a short summary of their discussion. A moderator will then open a discussion amongst all attendees addressing the most critical questions facing the industry.
6:30 Close of Day One
|
